Literature DB >> 932208

Lymphokine stimulation of collagen accumulation.

R L Johnson, M Ziff.   

Abstract

Lymphokine-rich supernates from normal human peripheral blood mononuclear cells, stimulated by the mitogen phytohemagglutinin, have been shown to cause enhanced collagen accumulation by human embryonic lung fibroblasts (WI-38), as measured by hydroxyproline content of fibroblast monolayers, [14C] proline incorporation into soluble collagen and collagenase release of radioactivity in supernates and monolayers of cultures incubated with [14C] proline. This fibroblast-stimulating activity, demonstrable by suitable dilutions of the supernates, coexisted with a number of other lymphokine activities such as lymphotoxin, proliferation inhibitory factor, and cloning inhibitory factor, which tend to reduce the numbers of function of fibroblasts. The increased content of collagen appeared to be the product of selected surviving and responding fibroblasts. The factor causing this increased collagen accumulation was nondialyzable and stable at -70 degrees C. It represents the first described lymphoid cell-derived activity capable of enhancing collagen accumulation. Fibroblast-stimulating activity may be implicated in the abnormal fibrosis seen in association with chronic inflammation in a variety of disease states. It may have special relevance to progressive systemic sclerosis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 932208      PMCID: PMC333175          DOI: 10.1172/JCI108455

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  Systemic scleroderma, A clinical study of 727 cases.

Authors:  D L TUFFANELLI; R K WINKELMANN
Journal:  Arch Dermatol       Date:  1961-09

2.  Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins.

Authors:  B Peterkofsky; R Diegelmann
Journal:  Biochemistry       Date:  1971-03-16       Impact factor: 3.162

3.  Polymyositis and cell-mediated immunity.

Authors:  M Ziff; R L Johnson
Journal:  N Engl J Med       Date:  1973-03-01       Impact factor: 91.245

4.  Antinuclear antibodies: their significance in scleroderma.

Authors:  R E Jordon; D Deheer; A Schroeter; R K Winkelmann
Journal:  Mayo Clin Proc       Date:  1971-02       Impact factor: 7.616

5.  Lymphocyte transformation in vitro. I. Tissue culture conditions and quantitative measurements.

Authors:  P T Schellekens; V P Eijsvoogel
Journal:  Clin Exp Immunol       Date:  1968-07       Impact factor: 4.330

6.  Connective tissue activation. I. The nature, specificity, measurement and distribution of connective tissue activating peptide.

Authors:  C W Castor
Journal:  Arthritis Rheum       Date:  1971 Jan-Feb

7.  "Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation.

Authors:  D C Dumonde; R A Wolstencroft; G S Panayi; M Matthew; J Morley; W T Howson
Journal:  Nature       Date:  1969-10-04       Impact factor: 49.962

8.  Uracil-specific anti-R.N.A. antibodies in scleroderma.

Authors:  D Alarcón-Segovia; E Fishbein; E García-Ortigoza; S Estrada-Parra
Journal:  Lancet       Date:  1975-02-15       Impact factor: 79.321

9.  The turnover of collagen in fibroblast cultures.

Authors:  J Steinberg
Journal:  J Cell Sci       Date:  1973-01       Impact factor: 5.285

10.  HOMOLOGOUS DISEASE IN THE ADULT RAT, A MODEL FOR AUTOIMMUNE DISEASE. I. GENERAL FEATURES AND CUTANEOUS LESIONS.

Authors:  P STASTNY; V A STEMBRIDGE; M ZIFF
Journal:  J Exp Med       Date:  1963-10-01       Impact factor: 14.307

View more
  69 in total

1.  Immunopathology of the lung: a review.

Authors:  K J Johnson; W E Chapman; P A Ward
Journal:  Am J Pathol       Date:  1979-06       Impact factor: 4.307

2.  The rate of synthesis of glycosaminoglycans and collagen by fibroblasts cultured from adult human liver biopsies.

Authors:  J T Galambos; M A Hollingsworth; A Falek; W D Warren; J R McCain
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

Review 3.  Pathogenesis of Systemic Sclerosis.

Authors:  Debendra Pattanaik; Monica Brown; Bradley C Postlethwaite; Arnold E Postlethwaite
Journal:  Front Immunol       Date:  2015-06-08       Impact factor: 7.561

Review 4.  Polyclonal activators in pulmonary immune disease.

Authors:  W F Willoughby; J B Willoughby; G F Gerberick
Journal:  Clin Rev Allergy       Date:  1985-05

Review 5.  [Importance of fibroblast chemotaxis in wound healing and tumor cell evasion].

Authors:  H Mensing
Journal:  Klin Wochenschr       Date:  1985-02-15

6.  Absence of CD4 or CD8 lymphocytes changes infiltration of inflammatory cells and profiles of cytokine expression in skin wounds, but does not impair healing.

Authors:  Lin Chen; Nisha D Mehta; Yan Zhao; Luisa A DiPietro
Journal:  Exp Dermatol       Date:  2014-03       Impact factor: 3.960

7.  Immunohistologic and ultrastructural study of the sclerotic skin in chronic graft-versus-host disease in man.

Authors:  A Janin-Mercier; A Devergie; D Van Cauwenberge; J H Saurat; M Bourges; C M Lapiere; E Gluckman
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

8.  Effects of histamine on collagen synthesis by cultured fibroblasts derived from guinea pig skin.

Authors:  A Hatamochi; K Fujiwara; H Ueki
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

9.  Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis.

Authors:  J A Schmidt; C N Oliver; J L Lepe-Zuniga; I Green; I Gery
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

10.  Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma).

Authors:  H Kondo; B S Rabin; G P Rodnan
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.